BETR-002, which is in preclinical and IND-enabling studies, is based on honokiol, the active anxiolytic ingredient of magnolia bark. BetterLife’s pending method of use and formulations patent covers ...

Forward-looking statements speak only as of the date they are made. Scienture Holdings, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new ...

Digital transformation in pharma is an exciting period that will result in greater patient care through improved drug development and ... is not an overnight process. It can involve some trial ...